578 results on '"Moreso, Francesc"'
Search Results
2. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy
3. Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients
4. Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates
5. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
6. Ex vivo C5b-9 deposition test to monitor complement activity in clinical and subclinical aHUS and in transplantation-associated thrombotic microangiopathy (TA-TMA)
7. WCN24-2277 PERI-TRANSPLANT DESENSITIZATION WITH APHERESIS AND RITUXIMAB IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED DONOR-SPECIFIC ANTIBODIES AND A NEGATIVE CDC CROSSMATCH. A SINGLE EXPERIENCE CENTRE
8. Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy
9. A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients
10. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study
11. Live donor kidney transplantation. Situation analysis and roadmap
12. Trasplante renal de donante vivo. Análisis de situación y hoja de ruta
13. Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies.
14. Expression of Rejection-Associated Transcripts in Early Protocol Renal Transplant Biopsies Are Associated with Tacrolimus Exposure and Graft Outcome
15. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
16. Frailty and kidney transplant candidates
17. COVID-19 in transplant recipients: The Spanish experience
18. La fragilidad en candidatos a trasplante renal
19. Tocilizumab en el tratamiento del rechazo humoral crónico activo resistente a terapia estándar
20. Protocol for Optimizing the Use of Kidneys From Donors With Seropositivity for Hepatitis C Virus in Seronegative Recipients
21. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study
22. Exploring kidney allograft rejection: A proof-of-concept study using spatial transcriptomics
23. Kidney transplant from controlled donors following circulatory death: Results from the GEODAS-3 multicentre study
24. Trasplante renal con órganos procedentes de donación tras parada circulatoria controlada: resultados del estudio multicéntrico GEODAS-3
25. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study
26. COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?
27. Expression of Rejection-Associated Transcripts in Early Protocol Renal Transplant Biopsies Is Associated with Tacrolimus Exposure and Graft Outcome.
28. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial
29. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management
30. Prime Time for HLA Desensitization: Imlifidase in the Spotlight
31. A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis
32. PROTOCOL BASED ON HEPATITIS C VIRUS NUCLEIC ACID TESTING TO OPTIMIZE RENAL TRANSPLANT FROM SEROPOSITIVE DONORS TO SERONEGATIVE RECIPIENTS. AN EUROPEAN EXPERIENCE
33. Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
34. Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
35. Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy
36. ESHOL study reanalysis: All-cause mortality considered by competing risks and time-dependent covariates for renal transplantation
37. Reanálisis del estudio ESHOL: mortalidad por todas las causas considerando riesgos de competición y tiempo-dependientes para trasplante renal
38. Additional file 1 of Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients
39. Live donor kidney transplantation. Situation analysis and roadmap
40. Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study)
41. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation
42. Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
43. Tocilizumab en el tratamiento del rechazo humoral crónico activo resistente a terapia estándar
44. Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study
45. Apolipoprotein A-Ib as Biomarker of FSGS Recurrence After Kidney Transplantation: Diagnostic Performance in a Prospective Cohort and Assessment of its Prognostic Value
46. Tacrolimus and mycophenolate regimen and subclinical tubulo‐interstitial inflammation in low immunological risk renal transplants
47. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.
48. Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation
49. MO1017: Induction Immunosuppression and Outcome in Early Kidney Transplant Recipients with Covid-19
50. MO154: Enteric Budesonide in IGAN Nephropathy: A Real World Clinical Practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.